漢港控股(01663.HK)附屬公司實驗室取得CNAS認可證書
格隆匯1月29日丨漢港控股(01663.HK)公吿,公司旗下子公司浙江美測醫藥科技有限公司於近日獲中國合格評定國家認可委員會(CNAS)授予的實驗室認可證書,證書編號為CNASL14242,發證時間為2021年1月21日,有效期為6年。
此次浙江美測獲得CNAS實驗室認可,標誌着浙江美測實驗室的管理水準、檢測能力及整體實力均得到國家認可並已達到國際水準,對保障浙江美測研發服務品質、提升浙江美測研發水平及增強全球客户對浙江美測研發服務的認可度具有促進作用,有利於提升浙江美測的整體競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.